The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
Abstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previou...
| Published in: | Stem Cell Research & Therapy |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-06-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-024-03778-1 |
| _version_ | 1850263649102331904 |
|---|---|
| author | Gurparneet Kaur Sohi Naba Farooqui Arjunmohan Mohan Kamalnath Sankaran Rajagopalan Li Xing Xiang Y. Zhu Kyra Jordan James D. Krier Ishran M. Saadiq Hui Tang LaTonya J. Hickson Alfonso Eirin Lilach O. Lerman Sandra M. Herrmann |
| author_facet | Gurparneet Kaur Sohi Naba Farooqui Arjunmohan Mohan Kamalnath Sankaran Rajagopalan Li Xing Xiang Y. Zhu Kyra Jordan James D. Krier Ishran M. Saadiq Hui Tang LaTonya J. Hickson Alfonso Eirin Lilach O. Lerman Sandra M. Herrmann |
| author_sort | Gurparneet Kaur Sohi |
| collection | DOAJ |
| container_title | Stem Cell Research & Therapy |
| description | Abstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previous pre-clinical studies, we found hypoxic preconditioning (HPC) enhanced angiogenesis and suppressed senescence gene expression. Thus, we hypothesize that HPC would improve human MSCs by enhancing their functionality and angiogenesis, creating an anti-inflammatory and anti-senescence environment. Methods MSC samples (n = 12 each) were collected from the abdominal fat of healthy kidney donors (HC), hypertensive patients (HTN), and patients with hypertensive kidney disease (HKD). MSCs were harvested and cultured in Normoxic (20% O2) or Hypoxic (1% O2) conditions. MSC functionality was measured by proliferation assays and cytokine released in conditioned media. Senescence was evaluated by senescence-associated beta-galactosidase (SA-beta-gal) activity. Additionally, transcriptome analysis using RNA-sequencing and quantitative PCR (qPCR) were performed. Results At baseline, normoxic HTN-MSCs had higher proliferation capacity compared to HC. However, HPC augmented proliferation in HC. HPC did not affect the release of pro-angiogenic protein VEGF, but increased EGF in HC-MSC, and decreased HGF in HC and HKD MSCs. Under HPC, SA-β-gal activity tended to decrease, particularly in HC group. HPC upregulated mostly the pro-angiogenic and inflammatory genes in HC and HKD and a few senescence genes in HKD. Conclusions HPC has a more favorable functional effect on HC- than on HKD-MSC, reflected in increased proliferation and EGF release, and modest decrease in senescence, whereas it has little effect on HTN or HKD MSCs. |
| format | Article |
| id | doaj-art-e3f87e4acdf64951aa98a88b3a081f2b |
| institution | Directory of Open Access Journals |
| issn | 1757-6512 |
| language | English |
| publishDate | 2024-06-01 |
| publisher | BMC |
| record_format | Article |
| spelling | doaj-art-e3f87e4acdf64951aa98a88b3a081f2b2025-08-19T23:45:51ZengBMCStem Cell Research & Therapy1757-65122024-06-0115111510.1186/s13287-024-03778-1The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney diseaseGurparneet Kaur Sohi0Naba Farooqui1Arjunmohan Mohan2Kamalnath Sankaran Rajagopalan3Li Xing4Xiang Y. Zhu5Kyra Jordan6James D. Krier7Ishran M. Saadiq8Hui Tang9LaTonya J. Hickson10Alfonso Eirin11Lilach O. Lerman12Sandra M. Herrmann13Division of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicAbstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previous pre-clinical studies, we found hypoxic preconditioning (HPC) enhanced angiogenesis and suppressed senescence gene expression. Thus, we hypothesize that HPC would improve human MSCs by enhancing their functionality and angiogenesis, creating an anti-inflammatory and anti-senescence environment. Methods MSC samples (n = 12 each) were collected from the abdominal fat of healthy kidney donors (HC), hypertensive patients (HTN), and patients with hypertensive kidney disease (HKD). MSCs were harvested and cultured in Normoxic (20% O2) or Hypoxic (1% O2) conditions. MSC functionality was measured by proliferation assays and cytokine released in conditioned media. Senescence was evaluated by senescence-associated beta-galactosidase (SA-beta-gal) activity. Additionally, transcriptome analysis using RNA-sequencing and quantitative PCR (qPCR) were performed. Results At baseline, normoxic HTN-MSCs had higher proliferation capacity compared to HC. However, HPC augmented proliferation in HC. HPC did not affect the release of pro-angiogenic protein VEGF, but increased EGF in HC-MSC, and decreased HGF in HC and HKD MSCs. Under HPC, SA-β-gal activity tended to decrease, particularly in HC group. HPC upregulated mostly the pro-angiogenic and inflammatory genes in HC and HKD and a few senescence genes in HKD. Conclusions HPC has a more favorable functional effect on HC- than on HKD-MSC, reflected in increased proliferation and EGF release, and modest decrease in senescence, whereas it has little effect on HTN or HKD MSCs.https://doi.org/10.1186/s13287-024-03778-1Hypertensive kidney diseaseAdipose mesenchymal stem cellsHypoxia preconditioningAngiogenesisSenescence |
| spellingShingle | Gurparneet Kaur Sohi Naba Farooqui Arjunmohan Mohan Kamalnath Sankaran Rajagopalan Li Xing Xiang Y. Zhu Kyra Jordan James D. Krier Ishran M. Saadiq Hui Tang LaTonya J. Hickson Alfonso Eirin Lilach O. Lerman Sandra M. Herrmann The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease Hypertensive kidney disease Adipose mesenchymal stem cells Hypoxia preconditioning Angiogenesis Senescence |
| title | The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease |
| title_full | The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease |
| title_fullStr | The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease |
| title_full_unstemmed | The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease |
| title_short | The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease |
| title_sort | impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease |
| topic | Hypertensive kidney disease Adipose mesenchymal stem cells Hypoxia preconditioning Angiogenesis Senescence |
| url | https://doi.org/10.1186/s13287-024-03778-1 |
| work_keys_str_mv | AT gurparneetkaursohi theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT nabafarooqui theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT arjunmohanmohan theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT kamalnathsankaranrajagopalan theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT lixing theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT xiangyzhu theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT kyrajordan theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT jamesdkrier theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT ishranmsaadiq theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT huitang theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT latonyajhickson theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT alfonsoeirin theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT lilacholerman theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT sandramherrmann theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT gurparneetkaursohi impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT nabafarooqui impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT arjunmohanmohan impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT kamalnathsankaranrajagopalan impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT lixing impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT xiangyzhu impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT kyrajordan impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT jamesdkrier impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT ishranmsaadiq impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT huitang impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT latonyajhickson impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT alfonsoeirin impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT lilacholerman impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease AT sandramherrmann impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease |
